MPact Global Action provides an overall understanding of how the Global Fund works for those seeking to securing funding for their work.

HRI releases a briefing outlying the realities of incarceration rates for minor drug offences, and the severe health hazards associated therein.

The needs of people who menstruate, particularly women, have been routinely ignored and deprioritised by prison and state systems during the pandemic emergency.

UNODC confirms that the synthetic drug market in East and Southeast Asia has adapted to setbacks brought on by Covid-19, with production and trafficking surging once again.

SAT provides a contemporary overview of HIV prevention funding in Southern Africa in order to support efforts towards ending the epidemic.

EMCDDA's latest analysis of the drug situation in Europe focuses on illicit drug use, its related harms and supply networks, as well government harm reduction interventions.

The EU Civil Society Forum on Drugs lays out guidelines on how to make the involvement of civil society in drug policy more meaningful.

EHRA publishes the results of its survey on OST in order to develop practical recommendations that will help decision-makers and health providers to refine their approaches on the subject.

The 1st Brandenburg Forum was held to facilitate openness and to build upon the series of high-profile Brandenburg Forums on Drugs and Development Policies held in Germany since 2016.

The UN WGAD documents widespread human rights violations associated with the "war on drugs" leading to increased arbitrary detention.

HIV Policy Lab has compiled a policy brief highlighting seven laws and policies that countries should adopt to markedly reduce AIDS-related mortality figures by 2030.

Santo Jr. et al. offer further evidence on OAT's crucial role in prolonging and sustaining the lives of people with opioid dependence.

UNAIDS urges world leaders to adopt a bold political declaration on HIV at the United Nations General Assembly High-Level Meeting on AIDS.

CIVICUS sheds light on worsening conditions for the work of civil society, exacerbated by restrictions expanded during the COVID-19 pandemic.

WHO highlights progress, shortfalls and actions needed to achieve 2030 goals, including in terms of addressing sociostructural barriers to health, such as stigma and criminalisation.

MENAHRA presents an in-depth review of the development harm reduction responses in the region over the past decade.

Civil society calls on the UN General Assembly to commit to fair and unobstructed access to health and harm reduction services.

EHRA provides a series of recommendations for those who seek to offer professional, comprehensive care for women who use drugs and experience gender-based violence (GBV).

McDonald et al. suggest that age-focused explanations are insufficient to account for skyrocketing drug-related deaths, and call for an expansion of harm reduction provision.

C-EHRN provides advice to reduce the harms associated with the unintentional consumption of synthetic cannabinoids in contexts where drug checking services are not available.